BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15331059)

  • 1. The histologic spectrum of nonalcoholic fatty liver disease.
    Contos MJ; Choudhury J; Mills AS; Sanyal AJ
    Clin Liver Dis; 2004 Aug; 8(3):481-500, vii. PubMed ID: 15331059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.
    Mofrad P; Contos MJ; Haque M; Sargeant C; Fisher RA; Luketic VA; Sterling RK; Shiffman ML; Stravitz RT; Sanyal AJ
    Hepatology; 2003 Jun; 37(6):1286-92. PubMed ID: 12774006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C and nonalcoholic fatty liver disease.
    Ramesh S; Sanyal AJ
    Semin Liver Dis; 2004 Nov; 24(4):399-413. PubMed ID: 15605308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of nonalcoholic steatohepatitis.
    Liou I; Kowdley KV
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S11-6. PubMed ID: 16540761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease.
    Hjelkrem MC; Torres DM; Harrison SA
    Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.
    Younossi ZM; Gramlich T; Liu YC; Matteoni C; Petrelli M; Goldblum J; Rybicki L; McCullough AJ
    Mod Pathol; 1998 Jun; 11(6):560-5. PubMed ID: 9647594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease in individuals with severe obesity.
    Haynes P; Liangpunsakul S; Chalasani N
    Clin Liver Dis; 2004 Aug; 8(3):535-47, viii. PubMed ID: 15331062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future.
    Wieckowska A; McCullough AJ; Feldstein AE
    Hepatology; 2007 Aug; 46(2):582-9. PubMed ID: 17661414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease in the pediatric population.
    Lavine JE; Schwimmer JB
    Clin Liver Dis; 2004 Aug; 8(3):549-58, viii-ix. PubMed ID: 15331063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients.
    Valva P; De Matteo E; Galoppo M; Pedreira A; Giacove G; Lezama C; Marco I; Galoppo MC; Preciado MV
    Hum Pathol; 2008 Dec; 39(12):1816-22. PubMed ID: 18715620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program.
    Nayak NC; Vasdev N; Saigal S; Soin AS
    Hum Pathol; 2010 Mar; 41(3):425-30. PubMed ID: 19954815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
    McCullough AJ
    Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
    Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD
    Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.
    Wanless IR; Shiota K
    Semin Liver Dis; 2004 Feb; 24(1):99-106. PubMed ID: 15085490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic assessment of non-alcoholic fatty liver disease.
    Bondini S; Kleiner DE; Goodman ZD; Gramlich T; Younossi ZM
    Clin Liver Dis; 2007 Feb; 11(1):17-23, vii. PubMed ID: 17544969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
    Wong VW; Wong GL; Tsang SW; Hui AY; Chan AW; Choi PC; Chim AM; Chu S; Chan FK; Sung JJ; Chan HL
    Aliment Pharmacol Ther; 2009 Feb; 29(4):387-96. PubMed ID: 19035982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver enzymes and histology in obese patients with obstructive sleep apnea.
    Kallwitz ER; Herdegen J; Madura J; Jakate S; Cotler SJ
    J Clin Gastroenterol; 2007; 41(10):918-21. PubMed ID: 18090161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
    Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
    Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.